Showing results (371-380 of 1,072) with videos related to
Sort By:
Pageof 108
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 9, 2008
Early discharge in acute myocardial infarction after clinical and angiographic risk assessmentGiuseppina Branca, Davide Capodanno, Piera Capranzano, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 12, 2014
Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterizationDavide Capodanno, Margherita Ministeri, Fabio Dipasqua, et al.Nephron Extra|April 4, 2012
Reference renal artery diameter is a stronger predictor of contrast-induced nephropathy than chronic kidney disease in patients with high cardiovascular riskLuca Zanoli, Stefania Rastelli, Carmelita Marcantoni, et al.Heart (British Cardiac Society)|March 18, 2026
Post-acute coronary syndrome cardiovascular rehabilitation: insights into endpoints, biomarkers and clinical practiceLuigi Cutore, Denise Cristiana Faro, Carmelo Raffo, et al.Circulation. Cardiovascular Interventions|December 25, 2009
Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery diseaseDavide Capodanno, Maria Elena Di Salvo, Glauco Cincotta, et al.Journal of Cardiovascular Development and Disease|November 26, 2025
Diagnostic Predictive Scores of Amyloid Cardiomyopathy in Patients with Heart Failure with Preserved Ejection Fraction and Left Ventricular HypertrophyDenise Cristiana Faro, Fabrizia Romeo, Valentina Losi, et al.Expert Review of Cardiovascular Therapy|August 11, 2020
Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosisMarco Vitolo, Saad Javed, Davide Capodanno, et al.Pacing and Clinical Electrophysiology : PACE|March 3, 2025
Progressive Anatomical Evolution Leading to Loss of S-ICD Eligibility in Hypertrophic Cardiomyopathy: A Case ReportLuca Avolio, Paolo Zappulla, Daniela Dugo, et al.BMC Medical Genetics|September 7, 2007
Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery diseaseUgo Cavallari, Elisabetta Trabetti, Giovanni Malerba, et al.Journal of the American College of Cardiology|April 24, 2012
A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) studyDietmar Trenk, Gregg W Stone, Meinrad Gawaz, et al.Pageof 108